Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
Health Canada has approved Dysport (abobotulinumtoxinA) for the treatment of leg spasticity in children and teens ages 2 and older, including those with cerebral palsy. The treatment, which reduces ... Read more
ObsEva has started a proof-of-concept clinical trial of its compound OBE022’s ability to prevent or delay premature births, which are associated with the development of cerebral palsy and other ... Read more
Injections of Dysport (botulinum toxin) provide multiple benefits for children with leg spasticity caused by cerebral palsy (CP), according to a clinical trial that assessed treatment with repeat injections ... Read more
Researchers at two universities in the U.K. have managed to map where spontaneous brain activity occurs in healthy preterm infants. This advancement could lead to a better understanding of ... Read more
Renowned New York obstetrician and gynecologist Pedram Bral has endorsed the PreTRM blood test, which predicts a woman’s risk of having a pre-term baby. Pre-term birth is linked to cerebral palsy and several other ... Read more